Key result
CAF-derived POSTN fueled the migration and invasion of ovarian cancer cells by activating the PI3K/Akt pathway and inducing EMT, and its overexpression correlated with reduced overall survival.
Why the study?
Periostin is linked to metastasis in various cancers, but its effect on crosstalk between ovarian cancer cells and cancer-associated fibroblasts remains elusive.
Stromal-derived POSTN drives the remodeling of the pro-metastatic microenvironment in ovarian cancer, presenting a potential therapeutic target.
Stromal POSTN may stratify HGSC risk; leaves open whether targeting CAF-derived POSTN alters progression.
OBJECTIVE: Periostin (POSTN) overexpression observed in various cancer types is correlated with metastasis and tumor progression. However, its effect on the crosstalk between ovarian cancer cells and cancer-associated fibroblasts (CAFs) remains elusive. This study aims to ascertain the role of CAF-derived POSTN in the ovarian cancer microenvironment. METHODS: POSTN expression in high-grade serous ovarian cancer (HGSC) was detected through immunochemistry. Transwell assay was conducted to determine cell migration and invasion. POSTN was knocked down or overexpressed using lentiviral vectors. The potential downstream effects of POSTN were explored and verified by RNA sequencing and western blotting, respectively. In vitro metastatic capability of ovarian cancer cells regulated by POSTN was determined by indirect co-culture. RESULTS: POSTN was highly enriched in HGSC stromal components, particularly in fibroblasts, while its overexpression was correlated with reduced overall survival (OS). CAF-derived POSTN functioned as a ligand for integrin αvβ3, fueling the migration and invasion of ovarian cancer cells by activating the PI3K/Akt pathway and inducing the epithelial-mesenchymal transition (EMT). Additionally, the pro-metastatic properties and the activation of fibroblasts induced by TGF-β1 partly relied on POSTN. CONCLUSIONS: Stromal-derived POSTN drives the remodeling of the pro-metastatic microenvironment, which might be as a potential therapeutic target in patients with ovarian cancer.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2020) studied High-grade serous ovarian cancer. CAF-derived POSTN was evaluated on Cell migration, invasion, and overall survival. CAF-derived POSTN fueled the migration and invasion of ovarian cancer cells by activating the PI3K/Akt pathway and inducing EMT, and its overexpression correlated with reduced overall survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: